FDA Approves New Heart Drug MYQORZO for Obstructive HCM

The FDA has approved Cytokinetics' MYQORZO (aficamten), a groundbreaking treatment for adults with symptomatic obstructive hypertrophic cardiomyopathy to improve heart function and reduce symptoms.